73 related articles for article (PubMed ID: 32774500)
1. A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency.
Yang X; Smirnov A; Buonomo OC; Mauriello A; Shi Y; Bischof J; Woodsmith J; ; Melino G; Candi E; Bernassola F
Cell Death Discov; 2023 Oct; 9(1):365. PubMed ID: 37783677
[TBL] [Abstract][Full Text] [Related]
2. Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.
Romero JM; Titmuss E; Wang Y; Vafiadis J; Pacis A; Jang GH; Zhang A; Golesworthy B; Lenko T; Williamson LM; Grünwald B; O'Kane GM; Jones SJM; Marra MA; Wilson JM; Gallinger S; Laskin J; Zogopoulos G
NPJ Precis Oncol; 2023 Aug; 7(1):73. PubMed ID: 37558751
[TBL] [Abstract][Full Text] [Related]
3. Negative Selection Allows DNA Mismatch Repair-Deficient Mouse Fibroblasts
Zhang L; Lee M; Hao X; Ehlert J; Chi Z; Jin B; Maslov AY; Barabási AL; Hoeijmakers JHJ; Edelmann W; Vijg J; Dong X
bioRxiv; 2024 May; ():. PubMed ID: 38766154
[TBL] [Abstract][Full Text] [Related]
4. Associating somatic mutation with clinical outcomes through kernel regression and optimal transport.
Little P; Hsu L; Sun W
Biometrics; 2023 Sep; 79(3):2705-2718. PubMed ID: 36217816
[TBL] [Abstract][Full Text] [Related]
5. NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients.
Giraud JS; Jouinot A; Pasmant E; Tlemsani C
NPJ Precis Oncol; 2024 Feb; 8(1):32. PubMed ID: 38341500
[TBL] [Abstract][Full Text] [Related]
6. Investigating low frequency somatic mutations in
Waneka G; Pate B; Monroe JG; Sloan DB
bioRxiv; 2024 Feb; ():. PubMed ID: 38352550
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutations in vascular wall function and age-associated disease.
Revêchon G; Merino LG; Machtel P; Eriksson M
Eur Heart J; 2023 Oct; 44(40):4208-4210. PubMed ID: 37477347
[No Abstract] [Full Text] [Related]
8. A rare case of sporadic mismatch repair deficient pancreatic ductal adenocarcinoma that responded to ipilimumab and nivolumab combination treatment: case report.
Han MY; Borazanci E
J Gastrointest Oncol; 2023 Feb; 14(1):458-462. PubMed ID: 36915432
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
Juhlin CC
Cancer Drug Resist; 2020; 3(4):992-1000. PubMed ID: 35582231
[TBL] [Abstract][Full Text] [Related]
10. Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.
Cho YA; Kim D; Lee B; Shim JH; Suh YL
J Neurooncol; 2021 May; 153(1):43-53. PubMed ID: 33864561
[TBL] [Abstract][Full Text] [Related]
11. Distinctive genomic characteristics in
He J; Ouyang W; Zhao W; Shao L; Li B; Liu B; Wang D; Han-Zhang H; Zhang Z; Shao L; Li W
Ann Transl Med; 2021 Jan; 9(2):129. PubMed ID: 33569431
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types.
Gong Z; Yang Y; Zhang J; Guo W
Cancer Biol Med; 2021 May; 18(4):1080-91. PubMed ID: 33960179
[TBL] [Abstract][Full Text] [Related]
13. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs).
Giustini N; Bazhenova L
Lung Cancer (Auckl); 2021; 12():21-34. PubMed ID: 33790679
[TBL] [Abstract][Full Text] [Related]
14. DNA mismatch repair in cancer.
Baretti M; Le DT
Pharmacol Ther; 2018 Sep; 189():45-62. PubMed ID: 29669262
[TBL] [Abstract][Full Text] [Related]
15. Somatic mutations in genes associated with mismatch repair predict survival in patients with metastatic cancer receiving immune checkpoint inhibitors.
Liu Y; Chen L; Zhang S; Shu Y; Qi Q; Zhu M; Peng Y; Ling Y
Oncol Lett; 2020 Oct; 20(4):27. PubMed ID: 32774500
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma.
Zhang W; Xia H; Yang R; Zhang Y; Zheng Q; Shang X; Liu N; Ma X; Wei C; Chen H; Mu X; Wang X; Liu Y
Front Immunol; 2022; 13():1030969. PubMed ID: 36426352
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
